It's promising, it won't be a "one shot fits all" I'm guessing.. would likely require months of treatment / monitoring. Would definitely be something used in conjunction with LLMab, if it pans out..

Quote:

---

It uses an adeno-associated virus (AAV) to deliver a one-time treatment [not likely] to functionally cure HIV infections. Preclinical studies show that it can excise HIV proviral DNA in multiple cell lines, including both human primary cells and multiple animal models and non-human primates.

---